| Ticker: | PATI | 46 Prince Street | |
| Exchange: | NASDAQ-National Market | Rochester, New York 14607 | |
| Industry: | Service | (716) 242-7200 |
| Type of Shares: | Common Shares | Filing Date: | 7/3/96 | |
| U.S. Shares: | 2,000,000 | Offer Date: | 12/19/96 | |
| Non-U.S. Shares: | 0 | Filing Price: | $12.00 | |
| Primary Shares: | 2,000,000 | Offer Price: | $8.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.56 | |
| Offering Amount: | $24,000,000 | Selling: | $0.31 | |
| Expenses: | - | Reallowance: | $0.10 | |
| Shares Out After: | 9,904,000 |
| Manager | Tier | Phone |
| Smith Barney Inc. | Lead Manager | (718) 921-8473 |
| Needham & Company | Co-manager | (212) 371-8300 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 3/31/96 | 3/31/96 | |||
| Revenue: | $0.11 | $0.17 | Assets: | $1.36 | |
| Net Income: | -$1.12 | -$0.57 | Liabilities: | $0.76 | |
| EPS: | -$0.14 | -$0.07 | Equity: | $0.60 | |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company provides patient-centered healthcare information systems that proactively collect and analyze information to improve patient compliance with prescribed treatments. The company's technology platform integrates treatment compliance algorithms with an advanced voice recognition telephone system, high speed data processing and analysis capability and demand publishing and information distribution capabilities. The system communicates directly with the patient at home in order to elicit relevant patient-specific data, evaluate the data and automatically transmit computer generated reports to health care payors, providers and patients tailored to the specific needs of each recipient. The company markets its services to pharmaceutical manufacturers, pharmacy benefit managers and health care payors and providers to collect data not obtained in a clinic setting and enhance compliance by patients with prescribed treatments. |
| Use of Proceeds |
| Proceeds from the proposed offering will be used for expanion of systems capabilities, for sales and marketing activities and for working capital and other general coporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.